A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.
Clinical trial NCT00989625 · COMPLETED
Trial details
- NCT number
- NCT00989625
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-04
- Primary completion
- 2009-09-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.